Company intelligence / Profile preview

T&R Biofab

Siheung-si, Gyeonggi-do, South Koreatnrbiofab.com ↗

Ownership: Private
Development stage: Commercial

Overview

T&R Biofab develops innovative solutions in tissue engineering and regenerative medicine using proprietary bioinks, biodegradable scaffolds, organoids, and advanced cell-printing technologies. The company has achieved notable milestones such as the world’s first bioprinted trachea transplant in March 2024. Its products are primarily at pre-clinical to early clinical stages with a focus on enabling next-generation therapies for tissue repair and organ replacement

Therapeutic areas: OtherPulmonology
Modalities: Cell therapyOrganoid-based therapyScaffold (biomaterial)Device (3D printed medical device)Biologic (bioink)
Industry: Implantable Medical Devices

Drug pipeline

1 asset

iPSC-based cardiomyocytes

Commercial

Indications: Cardiovascular disease

Partnerships

Collaborative research with POSTECH (Pohang University of Science & Technology) surgeons/hospitals

Beyond the preview

Go deeper on T&R Biofab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on T&R Biofab.

Explore the full profile